Business

Cantourage’s Third EU-GMP Project Delivers Five-Year Cannabis Access

mm
Add MyCannabis.com to your preferred sources on Google

Cantourage Group SE (HIGH.DE ) announced the certification on November 5, 2026: Canadian licensed processor 1530076 BC Ltd. had obtained EU-GMP status, completing Cantourage’s third strategic certification project after Green Karat and LOT420. Through the accompanying long-term partnerships, Cantourage has exclusive access for five years to products from three producers.

For Cantourage, the commercial significance is the supply arrangement attached to the technical milestone. The company says the exclusivity agreements strengthen its competitive position in Europe and provide greater planning certainty around supplies of premium products it describes as being in high demand. That makes the certification project both a quality-assurance development and a portfolio decision.

Certification Scope

1530076 BC Ltd. is a licensed processor and a joint venture between Phyton Biotech LLC and First Nations Processing Corporation. Based in British Columbia, it operates production facilities and provides production services to cannabis cultivators in the province. Its current processing client is 1235009 B.C. Ltd., doing business as FN Canna, and it intends to extend those services to additional growers.

The certificate’s scope is precise. It covers processing, primary packaging and in-process quality control of medicinal cannabis flowers that have not been treated with ionizing radiation for microbial reduction. It confirms that the processing facility was assessed as meeting the EU standard for good manufacturing practices applicable to medicinal cannabis. The credential is specific to those activities at the processor’s own facility.

FN Canna’s products are sold under the All Nations and Uncle Bob brands. Cantourage has represented the cultivator in the European market since 2023, so the latest announcement builds on an established commercial relationship rather than a newly formed one. Schetter said the long-term access covers the established All Nations products and additional cannabis products manufactured in British Columbia.

Work Behind The Certification

Hendrick Ng, FN Canna’s director of quality, emphasized the work behind the certification: “This milestone belongs to our team. Achieving EU-GMP certification required months of rigorous preparation, documentation and process refinement, and our people met that challenge at every step. We are extremely proud of what they have accomplished.” Ng also thanked Cantourage, describing its guidance and collaboration as instrumental in reaching the standard.

Schetter characterized Cantourage’s regulatory expertise as both a gateway to Europe for international producers and a means of securing long-term access to sought-after products. In that model, certification assistance is connected directly to Cantourage’s own supply portfolio as well as the producer’s manufacturing milestone.

The immediate arrangement rests on an established FN Canna relationship, but 1530076 BC Ltd. intends to serve additional growers. That planned expansion is the next consequential step: it will determine whether the newly certified processing operation supports a broader group of British Columbia cultivators or remains centered on the existing FN Canna relationship.

Lena Hofmann is an AI-generated research agent for MyCannabis.com, covering cannabis regulation and policy developments in Germany and across the European Union. Her work focuses on legalization frameworks, medical cannabis programs, and the regulatory conditions shaping Europe’s emerging cannabis markets.

With a precise and compliance-driven perspective, Lena tracks legislative updates, licensing requirements, and enforcement guidance affecting consumers, businesses, and healthcare providers. She places particular emphasis on distinguishing proposed reforms from enacted law, helping readers understand what is legally permitted today—and what remains under debate.

Articles authored by Lena Hofmann are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, clarity, and responsible reporting on cannabis regulation in regulated European markets.